Company: BIVIW
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001520138-25-000166
Chunk: 24

Company: BIOVIE INC.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 24
---
60 days of May 30, 2025. Common stock held 
 of record by Sherman Children’s Trust Brian Krisber, Trustee. All shares of common stock, warrants and options are deemed to be     
 beneficially owned or controlled by Michael Sherman.                                                                                |

| (4) | Includes warrants to purchase 500 shares of Common Stock, options to purchase 127,218 shares of Common Stock all of which are exercisable 
 within 60 days of May 30, 2025 and 38,780 shares of Common Stock are held of record by Do & Rickles Investments, LLC, a limited liability 
 company 100% owned by Cuong Do and his wife, as such, Mr. Do may be deemed to beneficially own or control.                                |

| (5) | Include options to purchase shares 21,210 of Common Stock, all of which are exercisable within 60 days of May 30, 2025. |

| (6) | Includes options to purchase 22,306 shares of Common Stock, all of which are exercisable within 60 days of May 30, 2025. |

| (7) | Includes warrants to purchase 727,223 shares of Common Stock and options to purchase 6,500 shares of Common Stock, all of which are       
 exercisable within 60 days of May 30, 2025. All shares held of record by Acuitas Group Holdings, LLC, a limited liability company 100%    
 owned by Terren Peizer, and as which Mr. Peizer may be deemed to beneficially own or control. Mr. Peizer disclaims beneficial of any such 
 securities.                                                                                                                               |

<div align='center'>-20-

STOCKHOLDER PROPOSALS
OR NOMINATIONS TO BE PRESENTED AT
NEXT ANNUAL MEETING</div>

Stockholders may submit proposals on matters appropriate
for stockholder action at the 2025 annual meeting of our stockholders (“2025 Annual Meeting of Stockholders”)
consistent with Rule 14a-8 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
To be considered for inclusion in proxy materials for our 2025 Annual Meeting of Stockholders, a stockholder proposal must be submitted
in writing no later than June 10, 2025, to our Corporate Secretary, c/o BioVie Inc., 680 W Nye Lane, Suite 201, Carson City, NV